|
|
|
30.05.26 - 00:24
|
KBRA Assigns AA+ Rating to State of Illinois, Build Illinois Bonds (Sales Tax Revenue), Junior Obligation Series A and B of June 2026; Affirms Parity Debt; Stable Outlook (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA assigns a long-term rating of AA+ with a Stable Outlook to the State of Illinois (the "State"), Build Illinois Bonds (Sales Tax Revenue Bonds), Junior Obligation Series A and B of June 2026 (the "Junior Bonds"). KBRA additionally affirms the long-term rating of AA+ with a Stable Outlook for the State's outstanding parity Junior Obligation Build Illinois Bonds.
Key Credit Considerations
The rating actions were because of the following key credit considerations:
Credit Positives
Security provisions are strong and include a priority lien on State sales tax revenues (after debt service payments on the Senior Obligation Build Illinois Bonds), a continuing appropriation requirement, and strong non-impairment language.
Junior Bonds' additional bonds test (ABT) requires 10.2x coverage of MADS on combined debt outstanding, limiting the potential to overleverage.
The statewide sales tax base is expansive and diverse, highlighted by combined lien debt service co...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.05.26 - 16:45
|
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
|
|
|
According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.04.26 - 10:12
|
Trotz Horror-Chart: Ist dieser Dividendenkönig jetzt ein Kauf? (Ariva)
|
|
|
Die Aktie von Dividendenaristokrat Abbott Laboratories handelt technisch in schwacher Verfassung, doch die Bewertung und die Dividende werden immer attraktiver. Nicht nur Risiko: Auch Sicherheit im Depot ist wichtig! Bei aller Euphorie um die steile Erholungsrallye am US-Aktienmarkt, starken Quartalszahlen und neuen Allzeithochs insbesondere bei Technologiewerten, sollten Anlegerinnen und Anleger defensive Basiswerte nicht vergessen, denn die ......
|
|